DURECT Corporation (DRRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 10260 BUBB RD
CUPERTINO, CA 95014
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments43,48369,81040,73364,67434,31536,759
Cash and cash equivalents43,48349,84421,31234,92431,64429,375
Short-term investments  19,96619,42129,7502,6717,384
Receivables3,4236,4779402,3131,7572,376
Inventory, net of allowances, customer advances and progress billings2,1131,8701,8643,3833,4213,163
Inventory2,1131,8701,8643,3833,4213,163
Other undisclosed current assets2,3753,58019,5241,4592,2473,060
Total current assets:51,39481,73763,06171,82941,74045,358
Noncurrent Assets
Operating lease, right-of-use asset1,9433,4464,7496,066
Property, plant and equipment188227251469605929
Long-term investments and receivables   1,000   
Long-term investments   1,000   
Intangible assets, net (including goodwill)6,1696,1696,1696,3996,3996,399
Goodwill6,1696,1696,1696,3996,3996,399
Restricted cash and investments150150150150150150
Other noncurrent assets2562612611,1071,105277
Total noncurrent assets:8,70610,25312,58014,1918,2597,755
TOTAL ASSETS:60,10091,99075,64186,02049,99953,113
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:7,8966,7997,4798,3936,2577,031
Employee-related liabilities4,099    
Accounts payable3,106 1,6782,1091,5891,520
Accrued liabilities7,896 5,8016,2844,6685,511
Other undisclosed accounts payable and accrued liabilities(3,106)2,700    
Deferred revenue 98 22,679
Debt21,170 8842,043 7,281
Deferred revenue and credits682
Other undisclosed current liabilities4,9383,1592,3403,6531,405834
Total current liabilities:34,00410,05610,70336,7687,66215,828
Noncurrent Liabilities
Long-term debt and lease obligation  22,45623,13824,77920,53312,634
Long-term debt, excluding current maturities  20,63219,93620,26220,53312,634
Liabilities, other than long-term debt1,1111,6961,6851,6131,8043,163
Deferred revenue and credits1,093
Deferred revenue  812812812
Contract with customer, liability812
Other liabilities8518848738019922,070
Operating lease, liability2601,8243,2024,517
Total noncurrent liabilities:1,11124,15224,82326,39222,33715,797
Total liabilities:35,11534,20835,52663,16029,99931,625
Equity
Equity, attributable to parent24,98557,78240,11522,86020,00021,488
Common stock232320191615
Additional paid in capital586,357583,818529,884512,046488,608465,246
Accumulated other comprehensive loss(13)(10)(5)(3) (1)
Accumulated deficit(561,382)(526,049)(489,784)(489,202)(468,624)(443,772)
Total equity:24,98557,78240,11522,86020,00021,488
TOTAL LIABILITIES AND EQUITY:60,10091,99075,64186,02049,99953,113

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues19,28313,97730,11129,56418,56449,170
Revenue, net49,170
Cost of revenue(1,588)(1,966)(1,406)(4,143)(4,263)(6,633)
Cost of goods and services sold(1,588)(1,955)(1,406)(4,143)(4,263)(6,633)
Gross profit:17,69512,01128,70525,42114,30142,537
Operating expenses(52,777)(46,284)(41,320)(44,572)(37,920)(44,774)
Operating loss:(35,082)(34,273)(12,615)(19,151)(23,619)(2,237)
Nonoperating income (expense)(251)(1,992)(1,720)(1,427)(1,703)(1,458)
Other nonoperating income (expense)2,1481565171,074870967
Interest and debt expense (2,399)(2,148)(2,237)(2,501)(2,573)(2,425)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before income taxes:(37,732)(38,413)(16,572)(23,079)(27,895)(6,120)
Other undisclosed income from continuing operations2,3992,1482,237   
Loss from continuing operations:(35,333)(36,265)(14,335)(23,079)(27,895)(6,120)
Loss before gain (loss) on sale of properties:(36,265)(582)(23,079)(27,895)(6,120)
Income from discontinued operations   13,753   
Other undisclosed net income    2,5012,573 
Net loss:(35,333)(36,265)(582)(20,578)(25,322)(6,120)
Other undisclosed net income attributable to parent      2,425
Net loss available to common stockholders, basic:(35,333)(36,265)(582)(20,578)(25,322)(3,695)
Other undisclosed net loss available to common stockholders, diluted      
Net loss available to common stockholders, diluted:(35,333)(36,265)(582)(20,578)(25,322)(3,695)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(35,333)(36,265)(582)(20,578)(25,322)(6,120)
Comprehensive loss:(35,333)(36,265)(582)(20,578)(25,322)(6,120)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)(5)(2)(3)12,427
Comprehensive loss, net of tax, attributable to parent:(35,336)(36,270)(584)(20,581)(25,321)(3,693)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: